# Tilly'S, Inc.: financial statements, quarterly TLYS · NYSE · CIK 1524025 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 28 Pages: [Overview](/companies/tlys.md) · [Financials](/companies/tlys/financials.md) · [Filings](/companies/tlys/filings.md) · [Insiders](/companies/tlys/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tlys/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [166](/filings/0001628280-24-050257.md) | [173 d](/filings/0001628280-26-024440.md) | [116](/filings/0001628280-25-029666.md) | [163](/filings/0001524025-25-000008.md) | [143](/filings/0001628280-25-055366.md) | [147 d](/filings/0001628280-26-024440.md) | [108](/filings/0001628280-26-040762.md) | [151](/filings/0001628280-26-060403.md) | [140](/filings/0001628280-25-055366.md) | [155 d](/filings/0001628280-26-024440.md) | [125](/filings/0001628280-26-040762.md) | [164](/filings/0001628280-26-060403.md) | | Cost of revenue | $m | [118](/filings/0001628280-24-050257.md) | [126 d](/filings/0001628280-26-024440.md) | [91.5](/filings/0001628280-25-029666.md) | [113](/filings/0001524025-25-000008.md) | [106](/filings/0001628280-25-055366.md) | [109 d](/filings/0001628280-26-024440.md) | [86.3](/filings/0001628280-26-040762.md) | [102](/filings/0001628280-26-060403.md) | [97.0](/filings/0001628280-25-055366.md) | [104 d](/filings/0001628280-26-024440.md) | [88.6](/filings/0001628280-26-040762.md) | [105](/filings/0001628280-26-060403.md) | | Gross profit | $m | [48.7](/filings/0001628280-24-050257.md) | [46.7 d](/filings/0001628280-26-024440.md) | [24.3](/filings/0001628280-25-029666.md) | [49.9](/filings/0001524025-25-000008.md) | [37.2](/filings/0001628280-25-055366.md) | [38.3 d](/filings/0001628280-26-024440.md) | [21.3](/filings/0001628280-26-040762.md) | [49.1](/filings/0001628280-26-060403.md) | [42.6](/filings/0001628280-25-055366.md) | [51.5 d](/filings/0001628280-26-024440.md) | [36.1](/filings/0001628280-26-040762.md) | [58.1](/filings/0001628280-26-060403.md) | | Selling, general and administrative | $m | [51.2](/filings/0001628280-24-050257.md) | [55.2 d](/filings/0001628280-26-024440.md) | [45.1](/filings/0001628280-25-029666.md) | [50.8](/filings/0001524025-25-000008.md) | [51.3](/filings/0001628280-25-055366.md) | [52.4 d](/filings/0001628280-26-024440.md) | [44.0](/filings/0001628280-26-040762.md) | [46.4](/filings/0001628280-26-060403.md) | [44.5](/filings/0001628280-25-055366.md) | [48.9 d](/filings/0001628280-26-024440.md) | [44.2](/filings/0001628280-26-040762.md) | [49.9](/filings/0001628280-26-060403.md) | | Operating income | $m | [(2.5)](/filings/0001628280-24-050257.md) | [(8.5) d](/filings/0001628280-26-024440.md) | [(20.8)](/filings/0001628280-25-029666.md) | [(0.9)](/filings/0001524025-25-000008.md) | [(14.1)](/filings/0001628280-25-055366.md) | [(14.1) d](/filings/0001628280-26-024440.md) | [(22.7)](/filings/0001628280-26-040762.md) | [2.7](/filings/0001628280-26-060403.md) | [(1.9)](/filings/0001628280-25-055366.md) | [2.6 d](/filings/0001628280-26-024440.md) | [(8.1)](/filings/0001628280-26-040762.md) | [8.2](/filings/0001628280-26-060403.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [(0.3)](/filings/0001628280-24-050257.md) | [13.6 d](/filings/0001628280-26-024440.md) | [(0.0)](/filings/0001628280-25-029666.md) | [(0.0)](/filings/0001524025-25-000008.md) | [(0.0)](/filings/0001628280-25-055366.md) | [0.2 d](/filings/0001628280-26-024440.md) | [(0.1)](/filings/0001628280-26-040762.md) | [(0.0)](/filings/0001628280-26-060403.md) | [0.0](/filings/0001628280-25-055366.md) | [0.0 d](/filings/0001628280-26-024440.md) | [0.1](/filings/0001628280-26-040762.md) | [0.1](/filings/0001628280-26-060403.md) | | Net income | $m | [(0.8)](/filings/0001628280-24-050257.md) | [(20.6) d](/filings/0001628280-26-024440.md) | [(19.6)](/filings/0001628280-25-029666.md) | [(0.1)](/filings/0001524025-25-000008.md) | [(12.9)](/filings/0001628280-25-055366.md) | [(13.7) d](/filings/0001628280-26-024440.md) | [(22.2)](/filings/0001628280-26-040762.md) | [3.2](/filings/0001628280-26-060403.md) | [(1.4)](/filings/0001628280-25-055366.md) | [2.9 d](/filings/0001628280-26-024440.md) | [(8.0)](/filings/0001628280-26-040762.md) | [8.4](/filings/0001628280-26-060403.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: not reported - Basic EPS: not reported ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [44.4](/filings/0001628280-24-050257.md) | [47.0](/filings/0001628280-25-017352.md) | [19.9](/filings/0001628280-25-029666.md) | [36.7](/filings/0001524025-25-000008.md) | [26.4](/filings/0001628280-25-055366.md) | [21.1](/filings/0001628280-26-024440.md) | [27.2](/filings/0001628280-26-040762.md) | [50.7](/filings/0001628280-26-060403.md) | [39.0](/filings/0001628280-25-055366.md) | [46.3](/filings/0001628280-26-060403.md) | [31.2](/filings/0001628280-26-040762.md) | [52.3](/filings/0001628280-26-060403.md) | | Current assets | $m | [196](/filings/0001628280-24-050257.md) | [176](/filings/0001628280-25-017352.md) | [163](/filings/0001628280-25-029666.md) | [194](/filings/0001524025-25-000008.md) | [162](/filings/0001628280-25-055366.md) | [131](/filings/0001628280-26-024440.md) | [127](/filings/0001628280-26-040762.md) | [151](/filings/0001628280-26-060403.md) | [135](/filings/0001628280-25-055366.md) | [125](/filings/0001628280-26-060403.md) | [126](/filings/0001628280-26-040762.md) | [162](/filings/0001628280-26-060403.md) | | Total assets | $m | [476](/filings/0001628280-24-050257.md) | [430](/filings/0001628280-25-017352.md) | [410](/filings/0001628280-25-029666.md) | [429](/filings/0001524025-25-000008.md) | [387](/filings/0001628280-25-055366.md) | [342](/filings/0001628280-26-024440.md) | [334](/filings/0001628280-26-040762.md) | [346](/filings/0001628280-26-060403.md) | [317](/filings/0001628280-25-055366.md) | [311](/filings/0001628280-26-060403.md) | [317](/filings/0001628280-26-040762.md) | [347](/filings/0001628280-26-060403.md) | | Current liabilities | $m | [119](/filings/0001628280-24-050257.md) | [105](/filings/0001628280-25-017352.md) | [113](/filings/0001628280-25-029666.md) | [143](/filings/0001524025-25-000008.md) | [120](/filings/0001628280-25-055366.md) | [99.4](/filings/0001628280-26-024440.md) | [117](/filings/0001628280-26-040762.md) | [133](/filings/0001628280-26-060403.md) | [114](/filings/0001628280-25-055366.md) | [100](/filings/0001628280-26-060403.md) | [113](/filings/0001628280-26-040762.md) | [140](/filings/0001628280-26-060403.md) | | Total liabilities | $m | [311](/filings/0001628280-24-050257.md) | [285](/filings/0001628280-25-017352.md) | [284](/filings/0001628280-25-029666.md) | [302](/filings/0001524025-25-000008.md) | [273](/filings/0001628280-25-055366.md) | [242](/filings/0001628280-26-024440.md) | [255](/filings/0001628280-26-040762.md) | [263](/filings/0001628280-26-060403.md) | [235](/filings/0001628280-25-055366.md) | [226](/filings/0001628280-26-060403.md) | [239](/filings/0001628280-26-040762.md) | [260](/filings/0001628280-26-060403.md) | | Shareholders' equity | $m | [165](/filings/0001628280-24-050257.md) | [145](/filings/0001628280-26-024440.md) | [126](/filings/0001524025-25-000008.md) | [127](/filings/0001628280-25-055366.md) | [114](/filings/0001628280-25-055366.md) | [101](/filings/0001628280-26-060403.md) | [79.1](/filings/0001628280-26-060403.md) | [82.5](/filings/0001628280-26-060403.md) | [81.6](/filings/0001628280-25-055366.md) | [85.1](/filings/0001628280-26-060403.md) | [77.8](/filings/0001628280-26-060403.md) | [86.9](/filings/0001628280-26-060403.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(6.6) d](/filings/0001628280-24-050257.md) | [3.7 d](/filings/0001628280-26-024440.md) | [(25.7)](/filings/0001628280-25-029666.md) | [10.5 d](/filings/0001524025-25-000008.md) | [(23.0) d](/filings/0001628280-25-055366.md) | [(3.8) d](/filings/0001628280-26-024440.md) | [(8.1)](/filings/0001628280-26-040762.md) | [14.0 d](/filings/0001628280-26-060403.md) | [(10.4) d](/filings/0001628280-25-055366.md) | [8.6 d](/filings/0001628280-26-024440.md) | [(3.9)](/filings/0001628280-26-040762.md) | [22.4 d](/filings/0001628280-26-060403.md) | | Capital expenditure | $m | [4.2 d](/filings/0001628280-24-050257.md) | [3.4 d](/filings/0001628280-26-024440.md) | [2.1](/filings/0001628280-25-029666.md) | [2.5 d](/filings/0001524025-25-000008.md) | [2.1 d](/filings/0001628280-25-055366.md) | [1.5 d](/filings/0001628280-26-024440.md) | [1.5](/filings/0001628280-26-040762.md) | [0.5 d](/filings/0001628280-26-060403.md) | [1.3 d](/filings/0001628280-25-055366.md) | [1.3 d](/filings/0001628280-26-024440.md) | [1.4](/filings/0001628280-26-040762.md) | [1.4 d](/filings/0001628280-26-060403.md) | | Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | [0.0 d](/filings/0001628280-23-040437.md) | [0.0 d](/filings/0001628280-25-017352.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: not reported - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [30.1](/filings/0001628280-23-040437.md) | [29.8](/filings/0001628280-24-027254.md) | [29.8](/filings/0001628280-24-039692.md) | [29.9](/filings/0001628280-24-050257.md) | [30.0](/filings/0001628280-25-029666.md) | [30.0](/filings/0001524025-25-000008.md) | [30.1](/filings/0001628280-25-055366.md) | [30.1](/filings/0001628280-26-040762.md) | [30.3](/filings/0001628280-26-060403.md) | [30.1](/filings/0001628280-25-055366.md) | [30.1](/filings/0001628280-26-040762.md) | [31.2](/filings/0001628280-26-060403.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 11,976,582 at 2015-03-27, from the cover of the [10-K filed 2015-04-01](/filings/0001193125-15-116304.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.